Talk:Combretastatin A-4
Latest comment: 12 years ago by Edgar181 in topic List of references
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
List of references edit
The following list of references was added to the article, but apparently are not used to support specific content in the article. I'm moving them here in case anyone would like to use them to expand this article. -- Ed (Edgar181) 19:17, 16 August 2011 (UTC)
- Nam, N. Combretastatin A-4 Analogues as Antimitotic Antitumor Agents Current Medicinal Chemistry, 2003, 10, 1697-1722.
- Griggs, J; Metcalfe, J. C; Hesketh, R. Targeting tumor vasculature: the development of combretastatin A4 Lancet Oncol, 2001, 2, 82-87.
- Hori, K; Saito, S. Microvascular Mechanisms by which the Combretastatin A-4 Derivative AC7700 (AVE8062) Induces Tumor Blood Flow Stasis British Journal of Cancer, 2003, 89, 1334-1344.
- Mukund K. Gurjar, “Synthesis and Evaluation of 4/5-Hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-Restricted Analogues of Combretastatin A-4 as Novel Anticancer Agents” J. Med. Chem. 2007, 50, 1744-1753
- Tron, G; Pirali, T; Sorba, G; Pagliai, F; Busacca, S; Genazzani, A. Medicinal Chemistry of Combretastatin A4: Present and Future Directions Journal of Medicinal Chemistry, 2006, 49, 3033-3044.
- Pandit, Bulbul; Sun, Yanjun; Chen, Ping; Sackett, Dan; Hu, Zhigen; et al. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416 Bioorganic and Medicinal Chem, 2006, 14, 6492-6501
- Hamze, A. ; Rasolofonjatovo, E. ; Provot, O. ; Mousset, C. ; Veau, D. ; Rodrigo, J. ; Bignon, J. ; J-M Liu. ; Wdzieczak-Bakala, J. ; Thoret, S. ; Dubois, J. ; Brion, J.-D. ; Alami, M. B-Ring-Modified isoCombretastatin A-4 Analogues Endowed with Interesting Anticancer Activities. ChemMedChem 2011, 6, 2179-2191. doi:10.1002/cmdc.201100325